Found: 6
Select item for more details and to access through your institution.
Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 34, p. 2, doi. 10.2807/1560-7917.ES.2024.29.34.2400139
- By:
- Publication type:
- Article
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 45, p. 1, doi. 10.2807/1560-7917.ES.2022.27.45.2200217
- By:
- Publication type:
- Article
Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 24, p. 5, doi. 10.2807/1560-7917.es.2022.27.24.2200448
- By:
- Publication type:
- Article
Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 21, p. 27, doi. 10.2807/1560-7917.ES.2024.29.21.2300608
- By:
- Publication type:
- Article
Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 12, p. 16, doi. 10.2807/1560-7917.ES.2023.28.12.2200772
- By:
- Publication type:
- Article
Response to Letter to the Editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 4, p. 34, doi. 10.2807/1560-7917.es.2023.28.4.2300044
- By:
- Publication type:
- Article